[ARNA] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[ARNA] Arena Pharmaceuticals, Inc.
Announcement Date
14-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 57.70%
YoY- -135.48%
Quarter Report
ARNA's Result
ARNA's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 37 3,002 8,648 273 85,374 7,751 9,191 -60.08%
PBT -122,161 -88,311 -41,576 -17,027 38,378 -30,504 -32,022 24.97%
Tax 14,236 6,687 -110,265 2,610 1,854 485 -152 -
NP -122,161 -88,311 68,711 -13,684 38,572 -30,459 -32,061 24.95%
Tax Rate - - - - -4.83% - - -
Total Cost 122,198 91,313 -60,063 13,957 46,802 38,210 41,252 19.82%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -330,164.86 -2,941.74 794.53 -5,012.45 45.18 -392.97 -348.83 213.01%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -2.10 -1.76 1.39 -0.35 1.59 -1.26 -1.46 6.23%
EPS Diluted -2.10 -1.76 1.35 -0.35 1.58 -1.26 -1.46 6.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.